Moneycontrol PRO
HomeNewsBusinessEarningsAstraZeneca Pharma India Q1 net profit declines 13% at Rs 18.63 crore

AstraZeneca Pharma India Q1 net profit declines 13% at Rs 18.63 crore

The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

August 10, 2020 / 16:23 IST

Drug firm AstraZeneca Pharma India on Monday reported a 13.38 percent decline in its net profit to Rs 18.63 crore for the quarter ended June.

The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal,  AstraZeneca Pharma India said in a BSE filing.

Revenue from operations stood at Rs 193.57 crore for the quarter under consideration. It was Rs 204.56 crore for the same period year ago, it added.

The board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2020-21, the filing said.

Shares of AstraZeneca Pharma India were trading at Rs 3,381.65 per scrip on BSE, up 1.50 percent over previous close.

PTI
first published: Aug 10, 2020 04:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347